1762.TW · CCSB
Taiwan · RS rating 67 · As of 2026-10-08
| Price | 35.35 TWD |
|---|---|
| 1-day change | +4.3% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 56 / 35 / 75 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 45 / 56 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | -54.3% |
| Sales growth Q/Q | -15.5% |
| Distance from 52-week high | +16.4% |
| Market cap (USD) | $81.3M |